As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the data ...

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized ...

For the majority, papaya, melon, cabbage, and raisins are foods to be eaten. But for those in scientific study, they are ...

Let’s dig into the relative performance of Palantir Technologies (NASDAQ:PLTR) and its peers as we unravel the now-completed ...

Lab Thread Ltd, a UK-based life science software company, today announced the release of a free of charge version of the ...

Can free AI scanners replace enterprise SAST? Anthropic and OpenAI found 500-plus zero-days pattern-matching tools missed — and both scanners are free.

Four commodities will power AI, the new Industrial Revolution, says Nick Lawson ...

New NASA-level software framework reproduces DUT vs ΛCDM results, resolving Hubble and growth tensions with Δχ² = ...

DCF analysis suggests fair value between $200–$250 per share, supporting a "Buy" rating despite recent volatility and sector ...

Palantir Technologies (NASDAQ: PLTR) is trading at $157.39 on Monday, March 23, 2026 — up approximately 4.5% on the session as the broad tech rally driven by Trump's Iran ceasefire announcement lifted ...

The real question is no longer, “Did you get admission?” but rather, “What are you going to do next?” Today, we explore a ...